Loading...
Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
The coronavirus disease 2019 (COVID-19) pandemic is concerning for patients with neuroimmunological diseases who are receiving immunotherapy. Uncertainty remains about whether immunotherapies increase the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or increase...
Na minha lista:
| Udgivet i: | Nat Rev Neurol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7341707/ https://ncbi.nlm.nih.gov/pubmed/32641860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-0385-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|